Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Losartan Potassium. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107056756B reveals a method achieving 98.4% purity using cyclic amine catalysts, offering significant cost reduction and scalability for API manufacturing.
Patent CN105198863B reveals a novel crystallization method for Losartan, achieving 99.5% purity without salt conversion, offering significant cost reduction in API manufacturing.
Patent CN108047208B reveals a novel acid-hydrolysis method reducing losartan dimer impurities below 0.1%, offering significant cost reduction in pharmaceutical intermediates manufacturing.